Stock screener

BDX

Conviction 58HealthcareScan · Mon, Aug 10, 2026
BDX$179.62+1.56%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Thomas H. Kean
Vol MA14 2M
May 11May 28Jun 16Jul 6Jul 23Aug 10
BECTON DICKINSON & COSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.bd.com
Price179.62
Change+1.56%
Gap-0.23%
Rel volume1.24×
Avg volume1.94M
Avg $ vol318.91M
SMA 20163.19
SMA 50154.86
SMA 200171.49
Price vs 50+15.99%
Price vs 200+4.74%
MA stackmixed
50/200 cross
Supertrendup · 164.43
RSI (14)76
MACD hist1.64
MACD cross
Stoch %K / %D100 / 94
ADX (14)31
+DI / −DI44 / 12
RSI divergenceBearish
MACD divergenceBearish
ATR %+2.50%
ADR %2.50%
52w high210.02
52w low140.71
From 52w high-14.47%
Above 52w low+27.65%
New 52w highNo
SqueezeOff
Bollinger width21.55%
%B0.97
Donchian pos99.84%
Donchian high179.67
Donchian low148.34
AVWAP (52w high)159.22
vs AVWAP high+12.81%
AVWAP (52w low)157.75
vs AVWAP low+13.87%
OBV trendUp
Chaikin MF (20)0.32
Today vs 20d1.24×
Avg vol (14d)2M
Avg vol (20d)1.94M
Avg $ vol (20d)318.91M
Market cap48.93B
RS 3m (vs SPY)+9.70%
RS 6m (vs SPY)-28.47%
RS line new highNo
Trend template4/8
Technical rank58.0
1 week+5.53%
1 month+18.22%
3 months+20.20%
6 months-14.47%
1 year-4.29%
YTD-7.86%
P/E29.16
P/B2.00
P/S2.24
P/FCF12.59
EPS5.82
Div yield2.44%
ROE6.87%
ROA3.31%
Debt/Eq0.58
Current0.87
EV/EBITDA12.39
Gross margin34.69%
Net margin7.68%
Rev growth8.24%
EPS growth-1.58%
Price target189.00
Target upside5.22%
Analyst ratingBuy
Institutional113.67%
Ent. value62.48B
Revenue4.98B
Net income377M
Gross profit
Free cash flow3.89B
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out275.54M
Employees72K
ListedWed, Sep 25, 1963
Free float283.77M
Float %99.7%
Short interest10.38M
Days to cover5.8d
Short volume68.2%
Squeeze score55 / 100
Next earnings
EPS forecast
Last EPS vs est$3.23 vs $3.14
Last surprise+2.9% beat
Setup gradeC
Conviction58 / 100
Pattern quality
Tech rank58.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance170.16
Support144.17
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BDX · 10 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-05-21
Sell$1K–$15K
RK
Rohit Khanna
house · CA
Buy
Kevin Hern
Kevin Hern
house · OK · traded 2026-03-17
Sell$15K–$50K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-24
Sell$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-05-13
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-05
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in BDX · 4 buys · 6 sells

InsiderSideShares
Huffines Robert Luther
Director · Rights to Common Stock Under BD Deferred Compensation Plan · 2026-08-06
Grant189
Byington Carrie L
Director · Rights to Common Stock Under BD Deferred Compensation Plan · 2026-08-06
Grant94
Feld Michael
EVP, Chief Revenue Officer · Common Stock · 2026-07-27
Sell75
Feld Michael
EVP, Chief Revenue Officer · Common Stock · 2026-06-26
Sell75
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm · Common Stock · 2026-06-24
Sell1.1K
Polen Thomas E Jr
Chairman, CEO and President · Stock Appreciation Rights · 2026-06-01
Exercise20.21K
Polen Thomas E Jr
Chairman, CEO and President · Common Stock · 2026-06-01
Sell2.76K
Polen Thomas E Jr
Chairman, CEO and President · Common Stock · 2026-06-01
Disposition17.45K
Polen Thomas E Jr
Chairman, CEO and President · Common Stock · 2026-06-01
Exercise20.21K
Menziuso Peter
EVP and President, BDI · Common Stock · 2026-06-01
Grant14.26K

SEC filings

EDGAR filings in BDX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.